RSV protection rises with vaccine for older people and new infants
 
To supplement respiratory syncytial (RSV) virus vaccines, from September 2025, the NHS will offer monoclonal antibody nirsevimab to protect around 7,000 premature or high-risk babies and infants during their first RSV season.…